Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11.8Revenue (TTM) $M0.2Net Margin (%)-2,971.6Altman Z-Score-3.7
Enterprise Value $M-4.4EPS (TTM) $-1.2Operating Margin %-4,193.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-2,971.6Higher ROA y-yY
Price/Book0.710-y EBITDA Growth Rate %-26.6Quick Ratio35.6Cash flow > EarningsN
Price/Sales72.15-y EBITDA Growth Rate %-54.8Current Ratio35.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-23.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-27.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M3.9ROIC % (ttm)-549.6Gross Margin Increase y-yY

Gurus Latest Trades with APPY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

APPY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


APPY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hurd Donald RSVP & Chief Commercial Officer 2014-04-14Buy4,375$16.32-81.43view
Hurd Donald RSVP, Chief Commerical Officer 2012-09-21Buy1,875$15.92-80.97view
SCHOETTLER GAILDirector 2012-08-03Buy313$12.64-76.03view
Lundy StevePresident, CEO 2012-06-29Buy500$15.44-80.38view
PUSEY GREGORYVice President 2012-06-29Buy250$15.52-80.48view
Merson Michael RDirector 2012-06-29Buy125$15.36-80.27view
MCGONEGAL JEFFREYCFO 2012-06-28Buy625$15.36-80.27view
Colgin MarkChief Scientific Officer 2009-02-10Sell0$0-80.27view
Merson Michael RDirector 2008-07-01Sell0$0-80.27view

Quarterly/Annual Reports about APPY:

News about APPY:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
AspenBio Pharma Inc. Reports Operating Results (10-Q) Nov 05 2010 
AspenBio Pharma Inc. Reports Operating Results (10-Q) Aug 05 2010 
Weekly CFO Buys Highlight: AspenBio Pharma, Solarwinds, Affymetrix, Cascade Financial Corp., Bank of Jul 31 2010 
AspenBio Pharma Inc. Reports Operating Results (10-Q) Nov 05 2009 
AspenBio Pharma Inc. Reports Operating Results (10-Q) Aug 07 2009 
AspenBio Pharma Inc. (APPY) CEO Daryl Faulkner buys 10,000 Shares May 21 2009 
AspenBio Pharma Inc. (APPY) COO & Chief Medical Officer Robert Frederick Caspari buys 3,200 Shares May 19 2009 

More From Other Websites
VENAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 27 2016
Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4) Sep 23 2016
Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4) Sep 23 2016
Venaxis Issues Shareholder Update Sep 20 2016
Venaxis Issues Shareholder Update Sep 19 2016
VENAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure Sep 19 2016
VENAXIS, INC. Files SEC form 8-K, Other Events Sep 14 2016
Venaxis Announces Acquisition of BiOptix Sep 13 2016
VENAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 13 2016
Venaxis Announces Acquisition of BiOptix Sep 13 2016
7 Stocks Under $10 Making Big Up Moves Aug 24 2016
VENAXIS, INC. Financials Aug 23 2016
VENAXIS, INC. Files SEC form 10-Q, Quarterly Report Aug 10 2016
MGT Stock Falls From 3 1/2-Year High May 18 2016
VENAXIS, INC. Files SEC form 10-Q, Quarterly Report May 11 2016
VENAXIS, INC. Files SEC form 8-K, Other Events Apr 14 2016
VENAXIS, INC. Files SEC form 8-K, Other Events Apr 04 2016
VENAXIS, INC. Files SEC form 8-K, Other Events Mar 30 2016
VENAXIS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Mar 29 2016
Venaxis, Inc. :APPY-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)